Siemens Healthineers AG
Company Profile
Business description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2023) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (16% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (21%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. North America represents 41% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific including China the remainder.
Contact
Siemensstrasse 3
ForchheimBY91301
DEUT: +49 9131843385
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2025
Employees
72,000
Siemens Healthineers AG News & Analysis
personal-finance
Simple but not easy: How to invest as Buffett intended
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,785.10 | 101.70 | 1.17% |
| CAC 40 | 7,946.83 | 55.15 | 0.70% |
| DAX 40 | 21,757.40 | 171.47 | 0.79% |
| Dow JONES (US) | 44,873.28 | 317.24 | 0.71% |
| FTSE 100 | 8,720.59 | 97.30 | 1.13% |
| HKSE | 20,891.62 | 294.53 | 1.43% |
| NASDAQ | 19,692.33 | 38.31 | 0.19% |
| Nikkei 225 | 39,066.53 | 235.05 | 0.61% |
| NZX 50 Index | 12,844.59 | 60.45 | -0.47% |
| S&P 500 | 6,061.48 | 23.60 | 0.39% |
| S&P/ASX 200 | 8,520.70 | 103.80 | 1.23% |
| SSE Composite Index | 3,270.66 | 41.17 | 1.27% |